DR. HARVEY I. CANTOR, M.D.
Medical Practice at Binney St, Boston, MA
License number
Massachusetts 37333
Category
Medical Practice
Type
Immunopathology
Address
Address
44 Binney St, Boston, MA 02115
Phone
(617) 632-3348
(617) 632-4630 (Fax)
(617) 632-4630 (Fax)
Personal information
See more information about HARVEY I. CANTOR at radaris.comName
Address
Phone
1 Beard Way, Wellesley, MA 02482
48 Ridge Hill Farm Rd, Wellesley, MA 02482
9 Edmunds Way, Belmont, MA 02478
290 Grove St, Wellesley, MA 02482
Professional information
Prof At Hms/Immunology
Position:
Benacerraf Prof of microbiol & Immunology/Chair Cancer Immunol DFCI at dfci
Location:
Greater Boston Area
Industry:
Research
Work:
dfci
since 1975
-
Benacerraf Prof of microbiol & Immunology/Chair Cancer Immunol DFCI
Harvey Ira Cantor, Boston MA
Specialties:
Allergy & Immunology, Clinical & Laboratory Immunology, Immunopathology
Work:
Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
44 Binney St, Boston, MA 02115
Education:
New York University (1967)
Dr. Harvey I Cantor, Boston MA - MD (Doctor of Medicine)
Specialties:
Family Medicine, Allergy & Immunology, Immunology
Address:
35 Binney St, Boston 02115
44 Binney St, Boston 02115
(617) 632-3348 (Phone), (617) 632-4630 (Fax)
44 Binney St, Boston 02115
(617) 632-3348 (Phone), (617) 632-4630 (Fax)
Languages:
English
Hospitals:
35 Binney St, Boston 02115
44 Binney St, Boston 02115
Dana - Farber Cancer Institute
450 Brookline Ave, Boston 02115
44 Binney St, Boston 02115
Dana - Farber Cancer Institute
450 Brookline Ave, Boston 02115
Education:
Medical School
New York University
Graduated: 1967
Stanford University Med Center
Ntnl Institute Of Med Research
New York University
Graduated: 1967
Stanford University Med Center
Ntnl Institute Of Med Research
Harvey I Cantor, Boston MA
Specialties:
Immunologist
Address:
44 Binney St, Boston, MA 02115
Assay Methods And Systems Utilizing Mast Cell Clones
US Patent:
4559310, Dec 17, 1985
Filed:
May 20, 1983
Appl. No.:
6/496543
Inventors:
Harvey I. Cantor - Boston MA
Gary Nabel - Cambridge MA
Gary Nabel - Cambridge MA
Assignee:
Dana Farber Cancer Institute - Boston MA
International Classification:
G01N 3354, C12Q 129
US Classification:
436519
Abstract:
The present invention is directed to an in vitro assay, useful in determining the effectiveness of anti-allergy compounds and/or useful in measuring the degree of sensitivity of a patient to particular allergens.
The present invention permits potential anti-allergy agents to be assayed in a number of ways. For example, the binding and dissociation rates of IgE to the mast cells in the presence and the absence of the substance being tested may be measured thereby giving a direct indication of that substance's ability to interfere with the IgE binding reaction. Another measure of a substance's potential as an anti-allergy agent is based upon the release of mediators or other compounds from the mast cells after sensitization by the allergen and exposure of the sensitized cells to the allergen.
The present invention generally involves the following steps:
(a) sensitizing cloned mast cells to an allergen;
(b) exposing sensitized mast cells to the allergen in the presence of a test anti-allergy agent; and
(c) measuring the reaction products of step (b) for an indication of test compound effect.
Lymphocyte Growth Factor
US Patent:
4613459, Sep 23, 1986
Filed:
Oct 20, 1982
Appl. No.:
6/435510
Inventors:
Harvey I. Cantor - Boston MA
Gary Nabel - Cambridge MA
Gary Nabel - Cambridge MA
Assignee:
Dana-Farber Cancer Institute - Boston MA
International Classification:
C07K 328, C12N 500, C12N 502, C12N 138
US Classification:
530351
Abstract:
A family of growth factors, methods of making and using such growth factors in in vivo treatment of living mammalian cells, and products incorporating such growth factors, are disclosed.
The growth factors were isolated from the supernatant fluid obtained by incubation of inducer T-cells in the presence of a suitable antigen or mitogen. The growth factors disclosed include a 14 Kd polypeptide which stimulates growth of both T-cells and B-cells, a 50 Kd polypeptide which stimulates B-cells to multiply and secrete immunoglobulins, and a 45 Kd growth factor which stimulates secretion of immunoglobulins by B-cells and stimulates rapid growth of certain mast cells, stem cells and certain other types of cells.